HomeAI · summaries
Storia in 16 fonti
3 Ebola vaccines being developed amid outbreak in Africa
Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
independent.co.uk
Moderna receives $50 million to develop Ebola vaccine as number of cases surge
This initiative is crucial as health authorities worldwide race to identify medical options and contain the outbreak, which has seen over 900 suspected cases and more than 220…
- ·
euronews.com
Health body fast-tracks three Ebola vaccines as virus continues spread
Global health body CEPI is fast-tracking three experimental vaccines against the Bundibugyo strain of Ebola as the outbreak in Central Africa continues to spread.
- ·
thenationalnews.com
Race for Ebola vaccine gets $50m boost as medics struggle to trace contacts | The National
Four nurses discharged from DR Congo hospital after recovering from virus
- ·
vanguardngr.com
'We need to act now': Race to develop Ebola vaccine heats up
While it marks the 17th Ebola outbreak in the DRC, it is just the third caused by the Bundibugyo strain, for which there are no...
- ·
arabnews.com
Moderna and other groups get $60m to develop Ebola vaccine
BENGALURU: Global health organization CEPI will give roughly $60 million to Moderna and to two other groups to accelerate the development of shots against Ebola Bundibugyo, the…
- ·
channel4.com
Ebola: $62 million pledge to speed up vaccine development
A global body set up to accelerate the development of vaccines has pledged $62 million to speed up progress on experimental jabs aimed at tackling the virus behind the Ebola…
- ·
arstechnica.com
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo
Amid a raging Ebola outbreak, officials "urgently accelerate development" of vaccines.
- ·
statnews.com
Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding
With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.
- ·
abc.net.au
Race to develop Ebola vaccine as deadly strain of virus spreads
Nearly 250 people are suspected to have died, and more than 1,100 are infected with the rare strain of Ebola in the DRC and Uganda, though the true spread of the virus is feared…
- ·
thejakartapost.com
Moderna and other groups get $60 million to develop Ebola vaccine - Middle East and Africa - The Jakarta Post
The Coalition for Epidemic Preparedness Innovations was one of the early investors that helped to develop a vaccine at the height of the COVID-19 pandemic.
- ·
nation.africa
Scientists target human trials for new Ebola vaccine 'within months'
This funding surge aims to fast-track vaccine candidates against the deadly Ebola Bundibugyo strain.
- ·
newsbytesapp.com
3 Ebola vaccines being developed amid outbreak in Africa
Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.
- ·
dailymail.com
Race to develop ebola vaccines is ON: Three jabs in development
Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014…
- ·
gulfnews.com
Race to develop Ebola vaccine heats up
Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.
- ·
aljazeera.com
What are the Ebola vaccines under research, and when will they be ready?
At least three vaccines are being funded, research being fast-tracked as the outbreak spreads faster than the response.
- ·
theguardian.com
The race to combat Ebola: what vaccines and treatments are being developed and how long will it take?
With the Bundibugyo strain of the disease spreading across the DRC and Uganda, scientists and researchers are trying to find rapid solutions
- ·
We talked to two scientists racing to find a new Ebola vaccine. Here’s what to know
The Oxford group is using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine
- ·
New vaccines will blunt the impact of future Ebola outbreaks, scientists say | The National
Amid the spread of the virus in the Democratic Republic of Congo, vaccine development is being fast-tracked